Equities

PZ Cormay SA

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CRM:WSE

PZ Cormay SA

Actions
Health CareMedical Equipment and Services
  • Price (PLN)0.418
  • Today's Change-0.002 / -0.48%
  • Shares traded44.95k
  • 1 Year change-8.13%
  • Beta0.6961
Data delayed at least 15 minutes, as of Feb 17 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

PZ Cormay SA is a Polish-based producer and wholesaler of diagnostic reagents and a distributor of the laboratory equipment. The Company is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. It offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.

  • Revenue in PLN (TTM)95.46m
  • Net income in PLN-2.37m
  • Incorporated2006
  • Employees207.00
  • Location
    PZ Cormay SAul. Wiosenna 22LOMIANKI 05-092PolandPOL
  • Phone+48 227517910
  • Fax+48 227517911
  • Websitehttps://cormay.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
CM International SA20.30m75.15k13.35m29.00177.691.9414.630.65790.06250.062516.875.721.091.7613.45634,319.100.40172.910.64084.8253.2248.560.37022.180.33652.120.00---45.60-1.34-830.29---39.09--
Inventionmed SA2.28m-2.52m21.50m7.00--63.21--9.42-0.0124-0.01240.01130.00170.0597--4.77421,033.20-6.58-16.92-10.78-23.6189.2720.44-110.24-9,913.55---0.65140.00--45,434.4346.61-133.21--8.75--
Nestmedic SA1.05m-4.71m32.14m4.00--4.81--30.50-0.1443-0.14430.03180.1320.08650.08639.95263,407.50-38.69-51.03-81.46-103.2669.9050.87-447.08-466.680.3988-20.590.1194---37.3918.8820.53------
Airway Medix SA4.00k835.00k33.70m1.00----35.078,426.09-0.0075-0.00750.00005-0.09930.0006--0.00314,000.0012.04-45.63---104.76-625.00--20,875.00-16,685.110.11674.873.35--0.00-47.26-258.21---69.08--
PZ Cormay SA95.46m-2.37m35.37m207.00--0.74229.860.3705-0.0281-0.02811.130.56591.093.125.54461,149.80-2.74-5.76-4.40-8.5138.4938.80-2.50-6.850.7137-1.240.1288--11.436.02-16.17---34.86--
BioMaxima SA60.73m649.00k53.46m126.0082.371.1412.460.88030.15480.154814.4811.160.79782.285.28481,976.200.852614.981.1119.2548.6941.641.0712.210.71061.480.2544--12.9612.06-8.70--6.75--
Advanced Medical Equipment SA1.20k23.10k64.08m5.002,781.6118.34--53,397.540.00090.00090.000050.1320.0003--0.0047--0.6529--0.6659------1,925.00------0.00--100.00---9.33------
Data as of Feb 17 2026. Currency figures normalised to PZ Cormay SA's reporting currency: Polish New Zloty PLN

Institutional shareholders

1.19%Per cent of shares held by top holders
HolderShares% Held
Generali PTE SAas of 31 Dec 2024963.81k1.15%
St. Galler Kantonalbank AG (Private Banking)as of 31 Jul 202440.00k0.05%
Data from 31 Oct 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.